
Comparing CRC-specific and Multi-Cancer Blood Tests
Compare colonoscopy, CT, stool DNA and blood tests for colorectal cancer screening—accuracy, intervals,
Episodes in this series

This episode, titled ‘Comparing CRC-specific and Multi-Cancer Blood Tests,’ features panelists examining the role of multi-cancer early detection (MCED) blood tests in colorectal cancer (CRC) screening and how they compare with CRC-specific screening approaches. As patient interest in blood-based testing grows, clinicians are increasingly faced with questions about whether these tests can replace traditional screening methods.
The discussion highlights key differences in purpose and performance between CRC-specific and multi-cancer screening approaches. Established CRC screening modalities, such as colonoscopy and stool-based tests, are designed specifically to detect colorectal cancer and demonstrate high sensitivity. In contrast, MCED tests cast a broader net, screening for multiple cancers simultaneously, but with lower sensitivity for CRC and without dedicated validation for colorectal cancer detection. As a result, these tests are not recommended as substitutes for guideline-based CRC screening but may serve as complementary tools in select scenarios.
The expert faculty also address practical considerations, including cost and access, noting that many MCED tests are not currently covered by insurance, which may limit their use. The conversation emphasizes the need for clear patient education and shared decision-making. Clinicians must help patients understand the limitations of these tests, including the potential for false positives and the reality that a negative result does not rule out cancer. This segment reinforces that while MCED tests represent an evolving area of innovation, CRC-specific screening remains the standard of care, and thoughtful integration of emerging tools requires careful clinical judgment.
In the next episode, ‘Stool-Based Colorectal Cancer Screening in Practice,’ panelists will discuss stool-based CRC screening options, which vary in sensitivity, convenience, and preparation requirements, making patient-centered selection essential. They also examine how effective communication and attention to practical factors can improve screening adherence and overall outcomes.



















































































































































































































